Skip to main content
Clinical Trials/NL-OMON45807
NL-OMON45807
Not yet recruiting
Not Applicable

Improving quality of care for patients with recurrent ovarian cancer - MOGYN21 QoC Ovarium Carcinoma

Radboud Universitair Medisch Centrum0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cancer of the ovary
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
300
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with recurrent EOC or tubal carcinoma or peritoneal carcinoma;
  • Histologically and/or cytologically proven epithelial ovarian cancer (including carcinosarcoma of the ovaries)
  • Measurable or evaluable disease confirmed by radiological imaging OR ca 125
  • ECOG \<\=2
  • Estimated life expectancy \>\=12 weeks
  • Patients must be accessible for treatment and follow\-up
  • Fit to receive chemotherapy

Exclusion Criteria

  • Patients with benign ovarian cancer;
  • Patients with non\-epithelial cancer;
  • Bowel obstruction, sub\-occlusive disease or presence of symptomatic brain metastases;
  • Patients with other malignancy occurring within 5 years before enrollment
  • Patients with impaired cognitive functioning or analphabetic patients
  • Patients with an inability to fill in surveys digitally

Outcomes

Primary Outcomes

Not specified

Similar Trials